Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

News | Antiplatelet and Anticoagulation Therapies

May 9, 2016 — A new study has found an increased risk of dementia in patients with atrial fibrillation (AF) that receive ...

Home May 09, 2016
Home
News | Atrial Fibrillation

May 9, 2016 — A new study presented at the Heart Rhythm Society’s 37th Annual Scientific Sessions, found that among ...

Home May 09, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

May 6, 2016 — Atrial fibrillation patients taking warfarin are at higher risk of developing kidney failure if ...

Home May 06, 2016
Home
Technology | Left Atrial Appendage (LAA) Occluders

April 29, 2016 — AtriCure Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the AtriClip PRO2 ...

Home April 29, 2016
Home
News | Atrial Fibrillation

April 20, 2016 — In the first large randomized trial to directly compare two approaches to preventing atrial ...

Home April 20, 2016
Home
Videos | Left Atrial Appendage (LAA) Occluders

David Holmes, M.D., professor of medicine, Mayo Clinic College of Medicine and consultant, Department of Internal ...

Home April 15, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

April 8, 2016 — New data from an ongoing post-marketing study confirm the safety profile of Xarelto (rivaroxaban) was ...

Home April 08, 2016
Home
Technology | Wearables

AliveCor, Inc., the leader in FDA-cleared electrocardiogram (ECG) technology for mobile devices, announced today the ...

Home March 28, 2016
Home
News | Pharmaceuticals

March 17, 2016 — Nearly half of all atrial fibrillation (AF) patients at the highest risk for stroke are not being ...

Home March 17, 2016
Home
News | Left Atrial Appendage (LAA) Occluders

March 16, 2016 — The Valley Hospital in Ridgewood, N.J., is one of 15 U.S. sites currently enrolling patients in a ...

Home March 16, 2016
Home
News | Remote Monitoring

March 14, 2016 — Biotronik announced that its BioMonitor 2 heart monitor is now available for patients in the United ...

Home March 14, 2016
Home
Technology

March 11, 2016 — Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the Blazer Open ...

Home March 11, 2016
Home
News | Structural Heart

February 18, 2016 — AtriCure Inc. announced that the first patient was enrolled and treated at PinnacleHealth Hospitals ...

Home February 18, 2016
Home
News | Left Atrial Appendage (LAA) Occluders

January 6, 2016 — A new study determined that the Watchman left atrial appendage closure device is more cost-effective ...

Home January 06, 2016
Home
Subscribe Now